Marubeni Construction Material Lease Co.,Ltd. Logo

Marubeni Construction Material Lease Co.,Ltd.

Leases and sells temporary steel materials and offers engineering for major construction projects.

9763 | T

Overview

Corporate Details

ISIN(s):
JP3878000003
LEI:
Country:
Japan
Address:
港区芝公園2丁目4番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Marubeni Construction Material Lease Co., Ltd. specializes in the leasing, sale, repair, and processing of temporary steel materials for the construction industry. The company's core product portfolio includes sheet piles, H-beams, steel supports, and steel decks. In addition to material provision, its engineering division offers planning and design services for temporary steel structures. The firm primarily supports the development of urban infrastructure and large-scale construction projects.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-11 02:19
Interim Report
確認書
Japanese 9.8 KB
2025-11-11 02:18
Interim Report
半期報告書-第58期(2025/04/01-2025/09/30)
Japanese 211.2 KB
2025-06-23 06:28
Post-Annual General Meeting Information
臨時報告書
Japanese 27.0 KB
2025-06-18 05:01
Registration Form
確認書
Japanese 10.1 KB
2025-06-18 05:00
Governance Information
内部統制報告書-第57期(2024/04/01-2025/03/31)
Japanese 28.5 KB
2025-06-18 04:59
Annual Report
有価証券報告書-第57期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2024-11-12 05:08
Interim Report
確認書
Japanese 9.4 KB
2024-11-12 05:06
Interim Report
半期報告書-第57期(2024/04/01-2025/03/31)
Japanese 205.8 KB
2024-06-21 02:39
Post-Annual General Meeting Information
臨時報告書
Japanese 25.4 KB
2024-06-20 06:56
Registration Form
確認書
Japanese 9.5 KB
2024-06-20 06:55
Governance Information
内部統制報告書-第56期(2023/04/01-2024/03/31)
Japanese 24.8 KB
2024-06-20 06:31
Registration Form
有価証券報告書-第56期(2023/04/01-2024/03/31)
Japanese 1.1 MB
2024-02-09 03:40
Quarterly Report
確認書
Japanese 9.4 KB
2024-02-09 03:39
Quarterly Report
四半期報告書-第56期第3四半期(2023/10/01-2023/12/31)
Japanese 182.3 KB
2023-11-13 05:18
Quarterly Report
確認書
Japanese 9.4 KB

Automate Your Workflow. Get a real-time feed of all Marubeni Construction Material Lease Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Marubeni Construction Material Lease Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Marubeni Construction Material Lease Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.